CMH Hematología
Consejo Mexicano de Hematología — Certificación en Hematología (Mexico)
Quick practiceEnglish
Exam overviewPractice session
An 80-year-old woman taking apixaban 5 mg twice daily for deep vein thrombosis presents with life-threatening gastrointestinal hemorrhage and shock; her last dose was 4 hours ago. The hospital does not stock andexanet alfa, which was withdrawn from the US market in December 2025 after post-marketing thrombotic safety signals. Besides resuscitation and source control, which is the recommended agent to reverse the factor Xa inhibitor effect?
Loading your practice session…